International antibodies producer ProteoGenix recently announced what it touts as the first Human Immune COVID-19 library for the fast discovery of potent antibodies against SARS-CoV-2. “Highly sensitive and specific antibodies are critical for the development of diagnostics, therapeutics, and prophylactics to fight against COVID-19,” said Philippe Funfrock, co-founder and president of ProteoGenix. “The new Human…